Stamford, Connecticut (PressExposure) March 26, 2012 -- Synowledge, LLC, a market leader widely known for its global and progressive approach to drug safety, regulatory affairs, and related IT services, is pleased to announce that it will be sponsoring the 2012 World Drug Safety Congress Americas in Boston, April 17-20.
The 2012 World Drug Safety Congress Americas is an annual conference hosted by Health Network Communications, a premier events company dedicated to serving the life sciences sector. The conference will feature expert speakers from industry leaders, including Abbott, AstraZeneca, Genzyme, Roche, Boehringer Ingelheim, Forest Laboratories, Health Canada, and Pfizer.
This year's meeting will address key challenges for drug safety and pharmacovigilance professionals worldwide, including:
Drug safety considerations specific to biopharmaceutical products
Implementation of global harmonization initiatives
Post-marketing safety surveillance techniques and operations
Risk minimization and management strategies
Industry and regulatory view point of pharmacovigilance audits and inspections
Dr. Seema Jaitly, Ph.D, Director, EU Pharmacovigilance & Risk Management at Synowledge will be presenting at the conference. The presentation is titled 'Safety Data Management within the Changing EU Regulations' and will provide attendees with invaluable insight into effectively navigating one of the largest changes in European drug regulations in over a decade.
As the official bag sponsor, Synowledge will be providing all attendees with a complimentary Synowledge travel bag. Synowledge will also be exhibiting throughout two days of the conference-- attendees are invited to visit Synowledge at booth #14 to learn more about our suite of drug safety, regulatory affairs and related IT services.
Session: World Drug Safety Congress Americas 2012
Date: April 17-20, 2012
Location: Hyatt Regency, Boston, USA
To view the full program, list of speakers and to register online please visit the World Drug Safety Congress Americas 2012 dedicated conference website: http://www.healthnetworkcommunications.com/2012/world-drug-safety-congress/
Synowledge is a global provider of drug safety, regulatory affairs and related IT solutions to small, mid and large sized pharmaceutical and biotechnology companies. Our comprehensive outsourcing solutions combine the unique strengths of both onshore and offshore services to meet our clients' needs. With more than 15 years of industry experience, our core team members have worked with leading pharmaceutical, biotech, medical device, and health care provider organizations. Synowledge is headquartered in Stamford, CT, USA with operation facilities located in Ohio, the United Kingdom, Germany, and India. For more information, please visit http://www.synowledge.com